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ABSTRACT:
INTRODUCTION: Antibiotic use in chronic periodon-
titis may result in improvement in periodontal status, although
many questions regarding the indications for this therapy re-
main unanswered. The polymicrobial etiology of the peri-
odontal infection hinders the choice of the proper antibiotic
agent. Furthermore the indiscriminate use of antibiotics could
lead to high levels of resistance and to various adverse reac-
tions.  In the recent years a various molecular diagnostics
protocols were proposed in order to facilitate the decision for
adjunctive antibiotic administration.
OBJECTIVE: The aim of this study is to compare the
microbiological effectiveness of adjunctive antibiotic admin-
istration with the mechanical periodontal therapy.
METHODS: 30 patients with severe chronic periodon-
titis were enrolled in this study and were divided in 3 groups:
Control group – with mechanical debridement only.
Test group 1 – with combined adjunctive antibiotic
administration using Amoxicillin+ Metronidazole.
Test group 2 – with target antibiotic administration ac-
cording to the resuts from the Real Time PCR identification.
RESULTS: The prevalence of all the isolated micro-
organisms (exept. E.nodatum and C.gingivalis) in Test Group
2 demonstrates statistically significant reduction compared
with the other treatment approaches. Almost complete elimi-
nation was registered for the consensus pathogens from the
red and orange complexes (above 99% and 100% for
P.intemedia).
CONCLUSION: The adjunct antibiotic treatment tar-
geted with Real-Time PCR identification demonstrates almost
complete elimination of the putative periodontal pathogens
in the deep periodontal pockets in patients with severe chronic
periodontitis. This result suggests slower recolonisation of
these habitats thus limiting the risk for progression of the peri-
odontal destruction.
Key words: severe chronic periodontitis, adjunctive
antibiotic therapy, periodontal pathogens, Real Time PCR
identification,
INTRODUCTION:
The microbial etiology of inûammatory periodontal
diseases provides the rationale for the use of antimicrobial
medication in periodontal therapy. As evidence for bacterial
specificity in periodontitis has accumulated and strengthened
over the past three decades, dentists have increased their use
of systemic antibiotics in periodontal therapy. This concept
is based on the premise that speciûc microorganisms cause
destructive periodontal disease and that the antibiotic agent
in vivo can exceed concentrations necessary to kill or inhibit
the pathogen(s).
The most effective use of antibiotics for the treatment
of periodontitis presupposes knowledge of the pathogenic
microbiota. At least 500 bacterial taxa have been identiûed
within periodontal pockets. [1]
However, relatively few species have been clearly as-
sociated with progressive periodontitis (Table 1)[2]. Most
putative pathogens are indigenous to the human oral cavity,
but possible superinfecting organisms (enteric Gram-negative
rods, pseudomonas, staphylococci, yeasts) may also inhabit
periodontal pockets. Periodontitis lesions usually harbor  a
constellation of putative pathogens rather than a single patho-
genic species. Most putative periodontal pathogens are Gram-
negative anaerobic rods. However, some pathogens are Gram-
positive facultative and anaerobic cocci and rods and others
are Gram-negative facultative rods. Putative periodontal
pathogens vary considerably in sensitivity to several antibi-
otics making simplistic approaches to antimicrobial chemo-
therapy problematic. [3]
Table 1. Association between putative periodontal pathogens and periodontitis.
Very strong Strong Moderate Unclear
A.actinomycetem-comitans B.forsythus S.intermedius Selenomonas sp.
P.gingivalis P.intermedia P. nigrescens Gr(-) intestinal MO
Spirochetes of acute C.rectus P. micros Staphylococcus sp.
necrotizing gingivitis E.nodatum F.nucLeaturn B. gracilis
Treponema  sp. Eubacterium sp.
E. corrodens
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In the last decades a lot of new data for periodontal
microbial etiology was acquired. Teles et al. [4] propose a
contemporary classification of putative periodontal pathogens
(Table 2). This new scheme does not replace the consensus
classification, but guves guidelines for further research
Fig.1. Microbial complexes in the periodontal environment. (Copied from Socransky SS, Haffajee AD. Periodontal
microbial ecology. Periodontology 2000, 2005; 38: 135–187)
The various microorganisms inhabiting the periodon-
tal environment and their complex relationships were pre-
sented by Socransky and Haffajee (2005) [5] and were united
in periodontal complexes (Fig.1).
Table 2. Putative periodontal pathogens
Consensus Strong Moderate Data for probable
pathogens association association association
Agregatibacter Eubacterium Campylobacter Acinetobacter baumannii
actinomycetemcomitans nodatum rectus
Porphyromonas Fusobacterium Dialister Bacteroides  strain AU126
gingivalis nucleatum pneumosintes
Tannerella Prevotella Eikenella Strains OP11 & TM7 phyla
forsythia intermedia corrodens
 Prevotella Filifactor Cryptobacterium
nigrescens alocis curtum
 Treponema Peptostreptococcus Deferribacteres
denticola micros  Strains D084 & BH017
   Selenomonas  sp. Enterococcus faecalis
   Streptococcus  milleri
group Escherichia coli
   Treponema Eubacterium
socranskii saphenum
     Exiguobacterium  aurantiacum
     Megasphaera  strain  BB166
     Mogibacterium  timidum
     Peptostreptococcus  magnus
     Porphyromonas  endodontalis
     Prevotella  corporis
     Prevotella  denticola
     Prevotella  disiens
     Slackia  exigua612 http://www.journal-imab-bg.org / J of IMAB. 2014, vol. 20, issue 5/
These complexes are used as framework for a better
understanding of the periodontal ecosystem. In the depend-
ence of the activity of the periodontal site changes of the in-
habiting complexes occur. The microorganisns from the red
complex are associated with the active periodontal lesions.
Patients with gingivitis or chronic periodontitis usu-
ally respond well to mechanical debridement and topical an-
tiseptics and may not derive clinically signiûcant additional
beneût from antibiotic therapy. [6]
However, evidence exists suggesting that antibiotic use
in chronic periodontitis may result in improvement in clini-
cal attachment level, although many questions regarding the
indications for this therapy remain unanswered. [7]
If antibiotics confer therapeutic advantage, should they
be given to all individuals? If not, then who should receive
these agents and how severe does the periodontal infection
have to be in order to justify the use of an antimicrobial agent?
There are no ‘‘evidence-based’’ guidelines for the use of sys-
temically administered antibiotics. It is recognized that many
factors impact on this decision such as the systemic well be-
ing of the patient, concomitant medical conditions, the nature
of the infecting agent(s), etc. For this reason, guidelines for
antibiotic use will always remain that; guidelines. They pro-
vide starting points to make complex decisions. In the treat-
ment of periodontal infections, we do not even have this start-
ing point, this guideline. We feel that antibiotics are useful
in the treatment of aggressive forms of periodontal diseases,
‘‘refractory’’ periodontitis and in smokers. However, in the
most common form of the disease, chronic periodontitis,
which patients would beneût from systemically administered
antibiotics and how would the decision to use antibiotics be
made?[8]
Many protocols for antibiotic administration are pro-
posed in the literature:
• Metronidazole [9]
• Amoxicillin [10]
• Clindamycin [11]
• Azithromycin [12]
• Doxycycline [13]
Combination drug therapy may be useful in periodon-
titis that involves a variety of periodontopathic species with
differing antimicrobial susceptibilities or to overcome the
drug-protective effects of the bioûlm. Also, therapeutic fail-
ure with some antibiotic regimens due to the presence or de-
velopment of resistant strains may be an emerging problem
in periodontal treatment. One strategy aimed at combating re-
sistant subgingival bacteria is the use of treatment regimens
that incorporate agents with complementary but different
mechanisms of action. Combination therapy should include
drugs that exhibit synergy or additiveeffects in vitro. Metro-
nidazole-amoxicillin act synergistically against Actinobacil-
lus actinomycetemcomitans and other major periodontal
pathogens.
• Amoxicillin  + Metronidazole [14,15]
The polymicrobial etiology of the periodontal infec-
tion hinders the choice of the proper antibiotic agent in the
periodontal treatment. Furthermore the indiscriminate use of
antibiotics could lead to high levels of resistance in the popu-
lation and to various adverse reactions.  In the recent years a
various molecular diagnostics protocols were proposed in or-
der to facilitate the decision for adjunctive antibiotic admin-
istration.
OBJECTIVE:
The aim of this study is to compare the microbiologi-
cal effectiveness of adjunctive antibiotic administration with
the mechanical periodontal therapy. Two protocols of antibi-
otic administration were tested - combined antibiotic treatment
with Amoxicillin + Metronidazole and target antibiotic admin-
istration according to the result of the Real Time PCR test.
METHODS:
The materials and methods are described in “Real time
pcr identification for target adjunctive antibiotic therapy of
severe chronic periodontitis. Part I - Clinical  results”.
1. Patient selection
70 patients were diagnosed and 30 patients were en-
rolled in this study
Inclusion criteria:
- Age – 18-75 years
- > 20 natural teeth in situ
- clinical and radiographic signs of severe chronic peri-
odontitis (CAL-loss of 5 mm or more at least at 20 sites)
- at least 6 pockets with PPD of 5 mm
- at least 4 pockets with PPDe”7mm
- no professional periodontal therapy during the 6
months preceding the baseline clinical evaluation
Exclusion criteria:
- have known systemic diseases that may influence the
periodontal conditions, in particular Down’s syndrome, known
AIDS/HIV or diabetes type I or II as determined by assess-
ment of erythrocyte HbA1c levels (more than 6.5%);
- regularly take drugs that may affect the periodontal
conditions, e.g. phenytoine, nifedipine, and/or anti-inflamma-
tory drugs;
- require antibiotic treatment for dental appointments;
- are undergoing or require extensive dental or ortho-
dontic treatment;
- are pregnant or breastfeeding;
- have any oral or extra oral piercing in or around the
oral cavity with ornaments or accessory jewelry;
- have participated in a clinical dental trial in the six
months preceding the study.
- have known allergies against the antibiotics to pre-
scribe.
- take antibiotics in the three months preceding the
study.
The patients enrolled in this study were divided in
three groups:
- Control group – with mechanical debridement only.
- Test group 1 – with combined adjunctive antibiotic
administration using Amoxicillin 500mg + Metronidazole
250mg tid – 7 days
- Test group 2 – with target antibiotic administration
according to the resuts from the Real Time PCR identifica-
tion.
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2. Anti-infective mechanical therapy - after oral hy-
giene  instructions and achievement of the proper oral hygiene
standard all patients received the same amount of full mouth
mechanical debridement.
3. Microbiological testing - a Real Time PCR test -
PET Test (MIP Pharma) was used in all patients. A pool sam-
ple with five sterile paper points from the pockets with
PPD≥7mm were taken on the baseline and on the 8 week
reevaluation.
This test provides information for:
A. Total Counts - MO
- Identified periodontal microorganisms – Ident
- Non-identifies microorganisms – No Ident
B. Quantity and prevalence of red complex:
- Porphyromonas gingivalis (Pg)
- Treponema denticola (Td)
- Tanerella forsythia (Tf)
C. Quantity and prevalence of some pathogens from
orange complex:
- Prevotella intermedia (P.i.)
- Peptosteptococcus (Micromonas) micros (Pm)
- Fusobacterium nucleatum (Fn)
D. Quantity and prevalence of some pathogens from
orange associated complex:
- Eubacterium nodatum (En)
E. Quantity and prevalence of some pathogens from
green complex:
- Capnocytophaga gingivalis (Cg).
F. Quantity and prevalence of   Aggregatibacer
actinomycetemcomitans (Aa).
The data analysis contained:
1. Initial levels
2. Microbial levels at reevaluation
3. Mean reduction of the microbial levels
4. Relative reduction - represents the relative share of
the changes in the microbial levels as a percentage from the
initial levels, thus allowing more accurate comparison be-
tween the different approaches.
4. Statistical analysis
The acquired data was analyzed with  IBM SPSS Sta-
tistics 19.0. The chosen level of significalce was p<0,05.
The following methods were aplied:
1. Descriptive analysis
2. Analysis of variations
3. Graphical analysis
4. Test χ2 Shapiro-Wilk test
5. ANOVA test
6. Kruskal-Wallis test
7. Student T -test
8. Mann-Whitney test
9. Wilcoxon test
RESULTS:
The analysis of the prevalence of the identified peri-
odontal microorganisms reveals reduction of their prevalence
after therapy in all treatment groups. A significantly greater
reduction of the prevalence is obtained in both test groups
(84,88% test group 1;  97,96% test group 2), compared to
the control group( 40,84%). In test group 2 an almost com-
plete elimination of the periodontal pathogens was achieved
(Fig.2).
In all treatment groups a slight increase of the preva-
lence of non-pathogen species was detected, as in the test
groups demonstrate statistically more pronounced increase
compared to the control group.
Fig. 2.Reduction of the prevalence of the detected microorganisms.614 http://www.journal-imab-bg.org / J of IMAB. 2014, vol. 20, issue 5/
A pronounced reduction of the prevalence of the peri-
odontal pathogens of the red complex (Fig. 3) was detected
in all treatment groups. In test group 2 the greatest reduction
was achieved with almost complete elimination of all patho-
gens (above 99, 8%). In the other treatment groups the re-
duction of the prevalence is with significantly lower levels.
These results imply a creation of a more stable microbiologi-
cal environment with diminished risk of progression of the
periodontal destruction with the application of the Real Time
PCR approach for the selection of the adjunctive antibiotic
therapy.
Fig. 3. Changes of the prevalence of the microorganisms of the “red complex”.
The data for the pathogens from the orange complex
(Fig.4.) reveals the differences between the applied ap-
proaches. The most pronounced reduction is reported in test
group 2 with elimination of P.intermedia and almost complete
absence of F. nucleatum (99,99 reduction of the prevalence).
In test group 1 also a reduction of the prevalence of these
pathogens is reported but with statistically significant lower
levels, whereas in the control group a fundamental increase
the prevalence  is present of F. nucleatum (150, 26% increase)
and P.intermedia (378,32% increase) compared with the
prevalence at baseline. The pathogens of the orange complex
play an  important role in the formation of the complex
biofilm and their higher levels of prevalence are associated
with increased risk of colonization with the pathogens of the
red complex and recurrence of the periodontal disease. These
results suggest that the adjunctive antibiotic therapy, espe-
cially using a Real Time PCR test for the selection of the an-
tibiotic could lead to a successful long-term result due to
slower recolonisation of the periodontal habitat with patho-
gens.
Fig. 4. Changes of the prevalence of the microorganisms of the “orange complex”./ J of IMAB. 2014, vol. 20, issue 5/ http://www.journal-imab-bg.org 615
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CONCLUSION:
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